Where

Contact

Pharmacist Program Objectives:

Stress Ulcer Prophylaxis:  Update on Recent Guidelines  (Application)
0172-0000-14-003-L01-P
1. Define stress ulcer bleeding and list associated risk factors in critically ill patients.
2. Compare and contrast the agents used for SUP.
3. Evaluate adverse events and safety issues associated with SUP.
4. Employ guidelines for stress ulcer prophylaxis

Oncology:  Biosimilars
(Application)
0172-0000-14-004-L01-P
1. Distinguish small and large biologics from traditional small molecule medications
2. Compare the current status and structure of the FDA approval pathways for biosimilars
3. Analyze clinical, legal, and operational considerations when determining whether or not to add biosimilars to health-system formularies
4. Apply knowledge of biosimilars to educate other healthcare personnel regarding differences in biosimilar approvals and traditional generic drug approvals

Uncontrolled Asthma:  Current Strategies for Hospital Pharmacists
(Application) 
0468-0000-14-003-L01-P
1. Describe the pathophysiology of asthma—including chronic inflammation, bronchial remodeling/ hyperresponsiveness, and bronchoconstriction
2. Define asthma control and determine appropriate monitoring strategies for patients with asthma
3. Recommend management strategies for the patient with difficult-to-control asthma in the emergency or in-patient setting
4. Develop discharge plans for asthma patients that include monitoring, medication, nonpharmacologic care, and follow-up plans along with adequate patient education on asthma
5. Apply management strategies for the patient with difficult-to-control asthma in the emergency or in-patient setting

Review of Updated Lipid Guidelines
(Application)
0172-0000-14-005-L01-P
1. Describe key points of the new ACC/AHA Guidelines to Reduce Atherosclerotic 
2. Cardiovascular Risk and how those guidelines were developed
3. Differentiate key differences between the ACC/AHA guidelines and those of ATP III
4. Describe strengths and limitations of the new ACC/AHA guidelines
5. Recognize aspects of lipid management in special populations that were not addressed in the new ACC/AHA guidelines
6. Determine a strategy to incorporate current evidence-based information into clinical practice based on current evidence

Review of Updated Hypertension Guidelines  (Application) 
0172-0000-14-006-L01-P 
1. Describe key points of the new JNC 8 Guidelines for the Management of Hypertension and how those were developed
2. Differentiate between the JNC 7 and JNC 8 guidelines
3. Describe the strengths and limitations of the new JNC 8 guidelines
4. Describe evidence related to hypertension management in the elderly
5. Based on current evidence, determine a strategy to incorporate current evidence-based information into clinical practice

Legislative/Board of Pharmacy Update
(Knowledge)
0172-0000-14-011-L03-P
Pharmacist Objectives:
1. List the current members of the Alabama Board of Pharmacy
2. Explain the differences in the processes involved in passing a law and promulgating a rule in Alabama
3. List pending legislation that will affect the practice of pharmacy in Alabama
4. Explain Stat Board initiatives and processes
5. Discuss current state board issues
6. Describe the current legislative issues at the local, state, and national levels

Antimicrobial Stewardship Project:  Results of Alabama Participants
(Knowledge)
0172-0000-14-008-L01-P
1. Discuss why antimicrobial stewardship (AMS) is needed and define AMS primary and secondary goals
2. Describe current AMS practices at hospitals in the state of Alabama:  Results of a 2013 survey
3. Identify AMS challenges and provide toos and protocols for improving AMS
4. Outline the Alabama Antimicrobial Stewardship Initiative (AASI) and opportunities for pharmacy involvement in AMS

Nutrition Support in the Critically Ill
(Application)
0172-0000-14-009-L01-P
1. Outline the impact of nutrition support in critical illness
2. Evaluate evidence related to the optimal timing of nutrition support in the intensive care unit
3. Assess clinical controversies in the provision of nutrition support in the critically ill

New Drug Update
(Knowledge)
0172-0000-14-010-L04-P
1. Describe indications, mechanism of action, dosage and administration, adverse effects, risk mitigation, cost, and drug interactions for selected medications approved by the FDA within the past 12 months
2. Compare and contrast the role of newly approved medications versus older medications
3. List important drugs withdrawn from the market in the past 12 months
4. Identify medications approved by the FDA in the past 12 months

**Technician Program Objectives:
 

Review of Updated Lipid Guidelines
(Knowledge)
0172-0000-14-012-L01-T
1. Describe key points of the new ACC/AHA Guidelines to Reduce Atherosclerotic 
2. Cardiovascular Risk and how those guidelines were developed
3. Differentiate key differences between the ACC/AHA guidelines and those of ATP III
4. Describe strengths and limitations of the new ACC/AHA guidelines
5. Recognize aspects of lipid management in special populations that were not addressed in the new ACC/AHA guidelines
6. Determine a strategy to incorporate current evidence-based information into clinical practice based on current evidence

Review of Updated Hypertension Guidelines  (Knowledge) 
0172-0000-14-013-L01-T 
1. Describe key points of the new JNC 8 Guidelines for the Management of Hypertension and how those were developed
2. Differentiate between the JNC 7 and JNC 8 guidelines
3. Describe the strengths and limitations of the new JNC 8 guidelines
4. Describe evidence related to hypertension management in the elderly
5. Based on current evidence, determine a strategy to incorporate current evidence-based information into clinical practice

Legislative/Board of Pharmacy Update
(Knowledge)
0172-0000-14-011-L03-T
1. List the current members of the Alabama Board of Pharmacy
2. Explain the differences in the processes involved in passing a law and promulgating a rule in Alabama
3. List pending legislation that will affect the practice of pharmacy in Alabama
4. Explain Stat Board initiatives and processes
5. Discuss current state board issues
6. Describe the current legislative issues at the local, state, and national levels